Amlod-valsa-hctz 5-160-12.5 MG 30S
Ended Awarded
- Contract number
- SPE2DR26F1LUC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,550
Award facts
- Contract value 100% obligated
- $4,550.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,550.16 by the Defense Logistics Agency on November 4, 2025, with completion scheduled for November 5, 2025. The delivery order, designated as AMLOD-VALSA-HCTZ 5-160-12.5 MG 30S, pertains to pharmaceutical products and represents a firm fixed-price, competitively awarded contract with no set-aside designation. This award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of medications, vaccines, and medical supplies to military healthcare systems worldwide.
The Defense Logistics Agency, under the Department of Defense, utilizes such delivery orders to procure critical pharmaceutical commodities for military medical supply chains and veteran healthcare systems. AmerisourceBergen's substantial IDC framework positions the company as a key vendor for federal medical procurement, capable of fulfilling diverse therapeutic needs across multiple therapeutic domains. The company's federal contract portfolio demonstrates extensive experience delivering both brand-name and generic pharmaceuticals, specialty medications, and medical supplies to support Defense Health Agency operations and other government healthcare customers globally.
Quick answers
Who was awarded contract SPE2DR26F1LUC?
SPE2DR26F1LUC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 4, 2025.
How much is contract SPE2DR26F1LUC worth?
The government has obligated $4,550 on SPE2DR26F1LUC.
Is contract SPE2DR26F1LUC an order under another contract?
Yes. SPE2DR26F1LUC is a delivery order under SPE2DR25D2215, an indefinite delivery contract.
Was contract SPE2DR26F1LUC competed?
The extent of competition for SPE2DR26F1LUC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award